Payment overview · 2025
General Payments
$223.58
2 reported records · 2 companies
Healthcare provider profile · identity verified
Jennifer Prince
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family · PENSACOLA, FL · NPI 1699134916
Verified facts
What the public records show
CMS Open Payments records show Jennifer Prince received $223.58 in general payments during 2025 across 2 reported records.
Vanda Pharmaceuticals Inc. accounted for 55.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $124.96 | 55.9% | 1 | 2025 |
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $98.62 | 44.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $223.58 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $124.96 | 1 | 2025 |
Source payment records
|
|||||
| LYBALVI Normalized: lybalvi |
Drug | Alkermes, Inc. | $98.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 372 | 43 |
| Amlodipine Besylate | Amlodipine Besylate | 331 | 42 |
| Trazodone Hcl | Trazodone Hcl | 262 | 36 |
| Lisinopril | Lisinopril | 239 | 29 |
| Levothyroxine Sodium | Levothyroxine Sodium | 234 | 31 |
| Furosemide | Furosemide | 229 | 34 |
| Gabapentin | Gabapentin | 225 | 27 |
| Quetiapine Fumarate | Quetiapine Fumarate | 219 | 27 |
| Losartan Potassium | Losartan Potassium | 193 | 29 |
| Potassium Chloride | Potassium Chloride | 185 | 23 |
| Metformin Hcl | Metformin Hcl | 142 | 19 |
| Sertraline Hcl | Sertraline Hcl | 139 | 13 |
| Divalproex Sodium | Divalproex Sodium | 137 | 16 |
| Eliquis | Apixaban | 133 | 17 |
| Tamsulosin Hcl | Tamsulosin Hcl | 128 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 127 | 17 |
| Benztropine Mesylate | Benztropine Mesylate | 118 | 11 |
| Buspirone Hcl | Buspirone Hcl | 115 | 17 |
| Carvedilol | Carvedilol | 108 | 14 |
| Simvastatin | Simvastatin | 107 | 14 |
| Metoprolol Succinate | Metoprolol Succinate | 103 | 13 |
| Lorazepam | Lorazepam | 98 | 18 |
| Omeprazole | Omeprazole | 87 | 15 |
| Myrbetriq | Mirabegron | 86 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 84 | suppressed |
| Escitalopram Oxalate | Escitalopram Oxalate | 82 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 79 | 14 |
| Donepezil Hcl | Donepezil Hcl | 73 | 11 |
| Oxybutynin Chloride | Oxybutynin Chloride | 73 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 72 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 71 | 11 |
| Famotidine | Famotidine | 69 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 68 | 11 |
| Haloperidol | Haloperidol | 65 | suppressed |
| Alprazolam | Alprazolam | 64 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 64 | 11 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 62 | suppressed |
| Aripiprazole | Aripiprazole | 57 | suppressed |
| Bupropion Xl | Bupropion Hcl | 57 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 55 | suppressed |
| Meloxicam | Meloxicam | 53 | suppressed |
| Risperidone | Risperidone | 52 | suppressed |
| Finasteride | Finasteride | 50 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 50 | suppressed |
| Glipizide | Glipizide | 48 | suppressed |
| Mirtazapine | Mirtazapine | 48 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 47 | 21 |
| Clonidine Hcl | Clonidine Hcl | 46 | suppressed |
| Levetiracetam | Levetiracetam | 46 | suppressed |
| Memantine Hcl | Memantine Hcl | 46 | suppressed |
| Baclofen | Baclofen | 44 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 43 | suppressed |
| Olanzapine | Olanzapine | 42 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 41 | 13 |
| Ezetimibe | Ezetimibe | 39 | suppressed |
| Nystatin | Nystatin | 39 | 19 |
| Fluoxetine Hcl | Fluoxetine Hcl | 38 | suppressed |
| Allopurinol | Allopurinol | 36 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 36 | 22 |
| Pregabalin | Pregabalin | 35 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 22 |
| Celecoxib | Celecoxib | 33 | suppressed |
| Ibuprofen | Ibuprofen | 30 | suppressed |
| Carbamazepine | Carbamazepine | 28 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 28 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 28 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 23 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 23 | suppressed |
| Methocarbamol | Methocarbamol | 23 | suppressed |
| Cefdinir | Cefdinir | 22 | 15 |
| Labetalol Hcl | Labetalol Hcl | 22 | suppressed |
| Digoxin | Digoxin | 21 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 21 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 21 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 20 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 20 | suppressed |
| Lidocaine | Lidocaine | 19 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 18 | 11 |
| Azithromycin | Azithromycin | 18 | 15 |
| Diazepam | Diazepam | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 17 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 17 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 17 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 17 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 16 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 16 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 16 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 16 | suppressed |
| Bumetanide | Bumetanide | 15 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 15 | suppressed |
| Indapamide | Indapamide | 15 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 15 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Clonidine | Clonidine | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Loperamide | Loperamide Hcl | 14 | 11 |
| Prednisolone Acetate | Prednisolone Acetate | 14 | suppressed |
| Timolol Maleate | Timolol Maleate | 14 | suppressed |
| Abilify Maintena | Aripiprazole | 13 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Calcitriol | Calcitriol | 13 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 13 | 12 |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Fesoterodine Fumarate Er | Fesoterodine Fumarate | 13 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 13 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 13 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 13 | suppressed |
| Methylprednisolone | Methylprednisolone | 13 | 11 |
| Nystop | Nystatin | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 13 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Valsartan | Valsartan | 13 | suppressed |
| Vraylar | Cariprazine Hcl | 13 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 13 | suppressed |
| Clonazepam | Clonazepam | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | suppressed |
| Glipizide Er | Glipizide | 12 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 12 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $223.58 · 2 records | Vanda Pharmaceuticals Inc. | FANAPT, LYBALVI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error